Follow

Alvotech Holdings S.A

Nasdaq First North Iceland (Iceland)

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. The company's purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
Go to market

Sector:
HEALTH CARE
>
Drug Manufacturers - Specialty & Generic
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
ALVO
LU2458332611
Nasdaq First North Iceland
Iceland (IS)
Details of share in Alvotech Holdings S.A with ticker ALVO
Status
Active
Amount of instruments
243 649 505
Currency
ISK
Listing
Sign in to buy
Market move
Sign in to buy
People
Mark Levick
CEO
Róbert Wessman
Chairman of the board
Lisa Graver
Board member
Arni Hardarson
Board member
Linda McGoldrick
Board member
Ann Merchant
Board member
Richard Davies
Board member
Tomas Ekman
Board member
Faysal Kalmoua
Board member
Company Details
Sector
HEALTH CARE

Address
9 rue de Bitbourg
Zip code
L-1273
City/district
Luxembourg
Country
Luxembourg (LU)
Phones
Registration number
B258884
LEI code
222100DCZBOWV5DZ8372
First trade date
23 Jun 2022
Registration date
02 Nov 2018
Short name
ALVO

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More